SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues

Marco M. Bühler; Junyan Lu; Sebastian Scheinost; Ferran Nadeu; Damien Roos-Weil; Manfred Hensel; Tharshika Thavayogarajah; Holger Moch; Markus G. Manz; Eugenia Haralambieva; Ewerton Marques Maggio; Sílvia Beà; Eva Giné; Elías Campo; Olivier A. Bernard; Wolfgang Huber; Thorsten Zenz

doi:10.1016/j.leukres.2021.106608

SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues

Marco M. Bühler, Junyan Lu, Sebastian Scheinost, Ferran Nadeu, Damien Roos-Weil, Manfred Hensel, Tharshika Thavayogarajah, Holger Moch, Markus G. Manz, Eugenia Haralambieva, Ewerton Marques Maggio, Sílvia Beà, Eva Giné, Elías Campo, Olivier A. Bernard, Wolfgang Huber, Thorsten Zenz

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

6 Citations (Scopus)

langue originale	Anglais
Numéro d'article	106608
journal	Leukemia Research
Volume	107
Les DOIs	https://doi.org/10.1016/j.leukres.2021.106608
état	Publié - 1 août 2021

Accès au document

10.1016/j.leukres.2021.106608

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Bühler, M. M., Lu, J., Scheinost, S., Nadeu, F., Roos-Weil, D., Hensel, M., Thavayogarajah, T., Moch, H., Manz, M. G., Haralambieva, E., Marques Maggio, E., Beà, S., Giné, E., Campo, E., Bernard, O. A., Huber, W., & Zenz, T. (2021). SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues. Leukemia Research, 107, Article 106608. https://doi.org/10.1016/j.leukres.2021.106608

@article{e53999ad75e7468c80e8756f5fda8173,

title = "SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues",

author = "B{\"u}hler, {Marco M.} and Junyan Lu and Sebastian Scheinost and Ferran Nadeu and Damien Roos-Weil and Manfred Hensel and Tharshika Thavayogarajah and Holger Moch and Manz, {Markus G.} and Eugenia Haralambieva and {Marques Maggio}, Ewerton and S{\'i}lvia Be{\`a} and Eva Gin{\'e} and El{\'i}as Campo and Bernard, {Olivier A.} and Wolfgang Huber and Thorsten Zenz",

note = "Funding Information: M.M.B. is supported by a research grant of the N uovo-Soldati Foundation for Cancer Research . T.Z. is supported by the Swiss Cancer League ( KFS-4439-02-2018 ), the Dornonville de la Cour-Stiftung , the Cancer Research Center (CRC) of the Comprehensive Cancer Center Zurich (CCCZ) and the Clinical Research Priority Program (CRPP) of the University of Zurich (“Precision Hematology/Oncology”). O.A.B. acknowledges the support of JTC 2014-143 (INCA 2016-049 ). Funding Information: M.M.B. is supported by a research grant of the Nuovo-Soldati Foundation for Cancer Research. T.Z. is supported by the Swiss Cancer League (KFS-4439-02-2018), the Dornonville de la Cour-Stiftung, the Cancer Research Center (CRC) of the Comprehensive Cancer Center Zurich (CCCZ) and the Clinical Research Priority Program(CRPP) of the University of Zurich (“Precision Hematology/Oncology”). O.A.B. acknowledges the support of JTC2014-143 (INCA 2016-049).",

year = "2021",

month = aug,

day = "1",

doi = "10.1016/j.leukres.2021.106608",

language = "English",

volume = "107",

journal = "Leukemia Research",

issn = "0145-2126",

}

Bühler, MM, Lu, J, Scheinost, S, Nadeu, F, Roos-Weil, D, Hensel, M, Thavayogarajah, T, Moch, H, Manz, MG, Haralambieva, E, Marques Maggio, E, Beà, S, Giné, E, Campo, E, Bernard, OA, Huber, W & Zenz, T 2021, 'SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues', Leukemia Research, VOL. 107, 106608. https://doi.org/10.1016/j.leukres.2021.106608

TY - JOUR

T1 - SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues

AU - Bühler, Marco M.

AU - Lu, Junyan

AU - Scheinost, Sebastian

AU - Nadeu, Ferran

AU - Roos-Weil, Damien

AU - Hensel, Manfred

AU - Thavayogarajah, Tharshika

AU - Moch, Holger

AU - Manz, Markus G.

AU - Haralambieva, Eugenia

AU - Marques Maggio, Ewerton

AU - Beà, Sílvia

AU - Giné, Eva

AU - Campo, Elías

AU - Bernard, Olivier A.

AU - Huber, Wolfgang

AU - Zenz, Thorsten

N1 - Funding Information: M.M.B. is supported by a research grant of the N uovo-Soldati Foundation for Cancer Research . T.Z. is supported by the Swiss Cancer League ( KFS-4439-02-2018 ), the Dornonville de la Cour-Stiftung , the Cancer Research Center (CRC) of the Comprehensive Cancer Center Zurich (CCCZ) and the Clinical Research Priority Program (CRPP) of the University of Zurich (“Precision Hematology/Oncology”). O.A.B. acknowledges the support of JTC 2014-143 (INCA 2016-049 ). Funding Information: M.M.B. is supported by a research grant of the Nuovo-Soldati Foundation for Cancer Research. T.Z. is supported by the Swiss Cancer League (KFS-4439-02-2018), the Dornonville de la Cour-Stiftung, the Cancer Research Center (CRC) of the Comprehensive Cancer Center Zurich (CCCZ) and the Clinical Research Priority Program(CRPP) of the University of Zurich (“Precision Hematology/Oncology”). O.A.B. acknowledges the support of JTC2014-143 (INCA 2016-049).

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85105442435&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2021.106608

DO - 10.1016/j.leukres.2021.106608

M3 - Letter

C2 - 33979727

AN - SCOPUS:85105442435

SN - 0145-2126

VL - 107

JO - Leukemia Research

JF - Leukemia Research

M1 - 106608

ER -